Page last updated: 2024-10-31

midazolam and Paralysis

midazolam has been researched along with Paralysis in 1 studies

Midazolam: A short-acting hypnotic-sedative drug with anxiolytic and amnestic properties. It is used in dentistry, cardiac surgery, endoscopic procedures, as preanesthetic medication, and as an adjunct to local anesthesia. The short duration and cardiorespiratory stability makes it useful in poor-risk, elderly, and cardiac patients. It is water-soluble at pH less than 4 and lipid-soluble at physiological pH.
midazolam : An imidazobenzodiazepine that is 4H-imidazo[1,5-a][1,4]benzodiazepine which is substituted by a methyl, 2-fluorophenyl and chloro groups at positions 1, 6 and 8, respectively.

Paralysis: A general term most often used to describe severe or complete loss of muscle strength due to motor system disease from the level of the cerebral cortex to the muscle fiber. This term may also occasionally refer to a loss of sensory function. (From Adams et al., Principles of Neurology, 6th ed, p45)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Godat, L1
Ravussin, PA1
Chiolero, R1
Bayer-Berger, M1
Freeman, J1

Other Studies

1 other study available for midazolam and Paralysis

ArticleYear
[Flumazenil and peroperative awakening in surgery of scoliosis].
    Annales francaises d'anesthesie et de reanimation, 1990, Volume: 9, Issue:1

    Topics: Adolescent; Adult; Aged; Anesthesia, General; Child; Female; Fentanyl; Flumazenil; Hemodynamics; Hum

1990